Physician profile
Michael H Burchell
NPI 1548655616
$13,678.84
in general payments reported to CMS, 2019-2025
57 companies · $4,932 in 2025
The $4,932 reported for 2025 was more than what 93% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $1,418 · 2021: $1,206 · 2022: $805 · 2023: $2,120 · 2024: $2,928 · 2025: $4,932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,647 · Travel and Lodging: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,647.07 |
| Travel and Lodging | $1,332.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,442.59 | 2021-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Boston Scientific Corporation | $2,251.59 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept, Accolade Sr |
| Nevro Corp. | $1,110.28 | 2020-2024 | Senza |
| Saluda Medical Americas, INC. | $1,055.18 | 2023-2025 | Evoke, Evoke Scs |
| Collegium Pharmaceutical, INC. | $515.63 | 2022-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $492.60 | 2021-2025 | Eterna, Proclaim |
| Spinal Simplicity, LLC | $430.51 | 2022-2023 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $408.45 | 2019-2020 | |
| Curonix LLC | $392.75 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $376.82 | 2023-2025 | Sprint Pns System |
| Janssen Biotech, INC. | $331.97 | 2020-2024 | Tremfya, Remicade, Simponi |
| Averitas Pharma INC. | $316.85 | 2024-2025 | Qutenza |
| Abbvie INC. | $303.85 | 2020-2023 | Ubrelvy, Qulipta |
| Mml US, INC. | $247.98 | 2023-2025 | Reactiv8 |
| Globus Medical, INC. | $191.12 | 2025 | Senza, Vyrsa V1 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.